This inventor holds 24 USPTO granted patents and 1 published patent application and 17 EPO patents, primarily in IDO Inhibitors. Top assignees: Merck Sharp + Dohme Corp., Lycera Corporation, Merck Sharp & Dohme LLC. Active years: 2016-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sudsbury, MA (US) (2018)
- Boston, MA (US) (2017 - 2020)
- Sudbury, MA (US) (2016 - 2022)
Company Filing History:
23 out of 2,405 
5 out of 36 
1 out of 67 Years Active: 2016-2026
Areas of Expertise:
Title: Innovations and Achievements of Nunzio Sciammetta
Introduction
Nunzio Sciammetta is a prominent inventor based in Sudbury, Massachusetts, known for his contributions to pharmaceutical sciences. With a remarkable portfolio of 22 patents, he has significantly impacted the field of drug discovery, particularly in the development of inhibitors for critical biological processes.
Latest Patents
Sciammetta's recent patents delve into the realm of indoleamine 2,3-dioxygenase (IDO) inhibitors. One notable patent describes substituted tetrahydroquinolin compounds, which showcase potential in the treatment or prevention of IDO-associated diseases or disorders. The patent emphasizes both the compound and its pharmaceutically acceptable salts, detailing their uses and compositions. Additionally, another patent features substituted biaryl compounds with similar therapeutic potential against IDO-related health issues, including comprehensive uses of these compounds and their respective compositions.
Career Highlights
Throughout his career, Nunzio Sciammetta has held significant roles at reputable organizations such as Merck Sharp & Dohme Corporation and Lycera Corporation. His work at these companies has allowed him to translate innovative ideas into practical pharmaceutical solutions, contributing to advancements in healthcare and medication efficacy.
Collaborations
Collaboration has been a key aspect of Sciammetta's success. He has worked alongside notable professionals such as Catherine M. White and Kun Liu. These partnerships have facilitated the exchange of ideas and enhanced the development of novel compounds aimed at addressing complex medical conditions.
Conclusion
Nunzio Sciammetta's impressive body of work exemplifies his dedication to innovation in the pharmaceutical industry. With a focus on developing effective IDO inhibitors, he continues to pave the way for future advancements in medical treatments. His collaborative efforts and extensive patent portfolio serve as a testament to his impact as an inventor and his commitment to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile